A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)
A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)
Active, not recruiting · NCT06706622 · Registry updated 2026-07-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA) | autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, primary dysautonomia, synucleinopathy | Active, not recruiting | Phase 3 | 2026-07-14 | NCT06706622 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| H. Lundbeck A/S | 16 |
74 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.